| 产品详情 |
| Edit |   |
| Product Name | Navitoclax (ABT 263) |
| Description | Purity ≥98%. A novel inhibitor of antiapoptotic BCL-2 proteins; a new Synonyms: 4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]benzamide; Navitoclax |
| Size | 5mg, 10mg, 50mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | 4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]benzamide; Navitoclax |
| Gene, Accession, CAS # | CAS: 923564-51-6 |
| Catalog # | 285063 |
| Price | |
| Order / More Info | Navitoclax (ABT 263) from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|